The Global "Endotracheal Tube Market" is expected to grow at a CAGR of 6.10% during the forecast period (2022-2029)
An endotracheal tube is a flexible plastic tube that is placed through the mouth into the trachea which is connected to a ventilator to deliver oxygen to the lungs. The tube is inserted when a patient is unable to breathe on their own. The process of inserting the tube is called endotracheal intubation. Endotracheal tubes are mostly made of polyvinyl chloride (PVC) and can be used only once.
The global endotracheal tube market is primarily driven by the increasing incidence of respiratory diseases such as pulmonary embolism, chronic obstructive pulmonary disorders, etc., growing preference for anesthesia laryngeal masks over ETTs, increasing need for intubation during severe injuries, and rising surgeries across the globe.
According to the study conducted by The Global Burden of Disease in 2016, 251 million cases of chronic obstructive pulmonary disorders (COPD) prevalence are noted worldwide.
According to the National Health Service in England, in 2018, the number of patients waiting for an operation on the NHS reached 4.3 million, the highest total for 10 years showing the increased number of surgeries.
However, high risk of post-surgical complications that arise after endotracheal intubation can restrain the market growth for endotracheal tubes.
Orotracheal tubes are expected to have the largest share in the intubation type segment of endotracheal tube market, the reasons being the product causes minimal pain, quickness, and convenience of performing laryngoscopic surgeries.
The orotracheal type of tubes is passed through the mouth into trachea hence easy to perform, while nasotracheal tubes are inserted through the nose and into the stomach to relieve excess air from the stomach which is less frequently used.
Coated endotracheal tubes are expected to witness significant growth in the product type segment during the forecast period owing to their property to limit bacterial growth to prevent coagulation. The endotracheal tubes are coated with antibiotic substances like silver, polyvinyl chloride (PVC), etc.
Hospitals are expected to dominate in the end user segment, while Ambulatory surgical centers are expected to show the highest growth in the forecast period.
The reasons can be attributed to the multiple areas of surgeries performed by placing an endotracheal tube including surgery with a general anesthetic, trauma, orthopedics, ophthalmology, oncology, cardiovascular, respiratory, neurology, endoscopy, laparoscopy, and cosmetics.
According to the Centers for Disease Control and Prevention (CDC), In 2017, the number of visits to physician offices is 1120.6 million, to hospital outpatient departments is 142.7 million and to hospital emergency departments are 154.8 million.
North America holds the major share of endotracheal tube market owing to the high prevalence of chronic diseases that require surgeries, technological advances in the region.
According to the U.S. National Library of Medicine, 9,686 clinical studies related to chronic diseases are conducted worldwide, out of which 3,934 clinical studies are conducted in North America alone. The U.S alone has 3,453 clinical studies.
For instance, in June 2017, Sanovas Inc. announced receiving a patent from the U.S. Patent and Trademark Office for its product, Imaging Stylet to be used for intubation. The stylet allows safer and quicker positioning of the endotracheal tube without losing control of the airway during endotracheal intubation.
According to the Centers for Disease Control and Prevention (CDC), In the U.S., 6 out of 10 adults have a chronic disease, of which 4 in 10 adults have two or more diseases.
The Asia Pacific is expected to have the highest growth in the coming years, mainly due to the developing countries.
According to the World Health Organization, chronic respiratory diseases are a leading cause of death in developing countries that account for around four million deaths per year. And it is estimated that more than 90% of COPD deaths occur in low and middle-income countries owing to pollution and tobacco smoking.
The strategies used by key players include mergers and acquisitions, partnerships, and product launches to expand and stand out as strong competitors in the market. New product launches along with an increased focus on R&D are other ways the leading players improve their market presence. The key players in the endotracheal tube market are C. R. Bard, ConvaTec, N8 Medical LLC, Bactiguard, Teleflex, Medtronic Plc, Smiths Medical, Parker Medical, Royax Medical Solution, and GE Healthcare.
For instance, on 8th February 2018, N8 Medical’s CeraShield Endotracheal tube, ceragenin coated ETT has been recognized as a breakthrough device by FDA designated by FDA.
On 30th October 2017, Inscope Medical launched Inscope Direct device, which is designed to eliminate the requirement of moving between yankauer suction and the endotracheal tube while securing the airway.
On 28th August 2018, Teleflex releases its U.S. based clinical study called CleanSweep closed suction system. The CleanSweep system uses both sweeping balloon technology and traditional suction collection to remove secretion build-up on the insides of endotracheal tubes.
Get your free sample proposal with a single click!